Cognitive impairment in patients with Parkinson's disease (PD) is one of the commonest and
most disabling non-motor manifestations during the course of the disease. The clinical …

Background Parkinson's disease has been identified as a risk factor for severe Coronavirus
disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death …

We have recently published the notion of the “vitals” of Parkinson's, a conglomeration of
signs and symptoms, largely nonmotor, that must not be missed and yet often not considered …

Abstract Patients with Parkinson's Disease (PD) often suffer from cognitive decline. Accurate
prediction of cognitive decline is essential for early treatment of at-risk patients. The aim of …

N-methyl-D-aspartate receptors (NMDARs) play essential roles in vital aspects of brain
functions. NMDARs mediate clinical features of neurological diseases and thus, represent a …

Parkinson's disease (PD) is the most common form of Parkinsonism, which is a group of
neurological disorders with PD-like motor impairments. The disease affects over 6 million …

Alzheimer's disease and Parkinson's disease are two of the most prevalent and disabling
neurodegenerative diseases globally. Both are proteinopathic conditions and while …

Cholinergic degeneration is significant in Lewy body disease, including Parkinson's
disease, dementia with Lewy bodies, and isolated REM sleep behavior disorder. Extensive …

Background: Parkinson's disease is a disabling degenerative disease of the central nervous
system that occurs mainly in elderly people. The changes in the incidence and mortality of …

Background Approximately one third of recently diagnosed Parkinson's disease (PD)
patients experience cognitive decline. The nucleus basalis of Meynert (NBM) degenerates …